Table 2. Clinical features of the patients with cancer with or without lymphedema.

	Cancer with lymphedema (Group 1)(n=63)				Cancer without lymphedema (Group 2) (n=40)
	n	%	Median	IQR	n	%	Median	IQR	p
Diagnosis									0.117a
Breast cancer	34	54.0			32	80.0
Ovarian cancer	14	22.2			5	32.5
Endometrium cancer	12	19.0			3	7.5
Prostate cancer	1	1.6			-	-
Urinary bladder cancer	2	3.2			-	-
Stage of cancer									0.118a
Stage 1	11	17.5			9	22.5
Stage 2	33	52.4			14	35.0
Stage 3	15	23.8			9	22.5
Stage 4	4	6.3			8	20.0
Metastasis									0.152b
Yes	11	17.5			12	30.0
No	52	82.5			28	70.0
History of surgery									0.015a
Yes	60	95.2			32	80.0
No	3	4.8			8	20.0
Number of surgeries									0.480a
1	53	84.1			27	67.5
2	6	9.5			5	12.5
3	1	1.69			-	-
History of chemotherapy									0.167a
Yes	57	90.5			39	97.5
No	6	9.5			1	2.5
History of radiotherapy									<0.001b
Yes	56	88.9			12	30.0
No	7	11.1			28	70.0
History of hormonal therapy									0.441b
Yes	10	15.9			9	22.5
No	53	84.1			31	37.5
Duration of lymphedema (month)			12.0	7.0-36.0			-	-
Stage of lymphedema
Stage 0	20	31.7			-	-
Stage 1	29	46.0			-	-
Stage 2	13	20.6			-	-
Stage 3	1	1.6			-	-
History of CDT
Yes	9	14.3			-
No	54	85.7			-
Mobilization									0.275a
Ambulation with support	11	17.5			5	12.5
Independent ambulation	52	82.5			35	87.5
Duration of taking caregiving			8.0	1.0-16.0			11.0	3.0-36.0	0.069c
Type of caregiving									<0.001b
Continuous	11	17.5			24	60.0
Intermittent	52	82.5			16	40.0
Place of taking caregiving									0.167a
Hospital	6	9.5			1	2.5
Home	57	90.5			39	37.5
Relationship of the caregiver									0.691a
Daughter	18	28.6			13	32.5
Son	9	14.3			5	12.5
Spouse	31	49.2			18	45.0
Sister/brother	2	3.2			2	5.0
Grandchild	3	4.8			-	-
Bride	-	-			1	2.5
Cousin	-	-			1	2.5
IQR: Interquartile range; CDT: Complex decongestive therapy; a Pearson chi-square test; b Fisher’s exact test; c Mann-Whitney U test.